“Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis”, J of Skin, vol. 6, no. 6, p. s52, Nov. 2022, doi: 10.25251/skin.6.supp.52.